Leaflet VASOVIST 0.25mmol / ml solution for injection

Indicated for: diagnostic imaging contrast enhancement

Route of administration: injectable

Substance: gadofosveset (contrast agent)

ATC: V08CA11 (Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Nephrotoxicity
Nephrotoxicity

This medicine may affect the kidneys.

Gadofosveset is a contrast agent used in magnetic resonance imaging (MRI) to visualize blood vessels and associated structures. It is a gadolinium-based contrast agent that binds to plasma proteins, providing detailed images.

This medication is administered intravenously and is primarily used for diagnosing cardiovascular diseases such as stenosis or thrombosis.

Adverse reactions may include nausea, headache, dizziness, or injection site reactions. In rare cases, severe allergic reactions or nephrogenic systemic fibrosis may occur in patients with kidney impairment.

It is important to inform your doctor about your medical history, especially kidney conditions, before receiving gadofosveset.

General data about VASOVIST 0.25mmol / ml

  • Substance: gadofosveset
  • Date of latest medicines list: 01-07-2013
  • Product code: W51785008
  • Concentration: 0.25mmol / ml
  • Pharmaceutical form: solution for injection
  • Quantity: 5
  • Product type: Original
  • Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.